Retinal Degeneration and Age-related Macular Degeneration
ONL Therapeutics Inc. focuses on atrophic age-related macular degeneration, with particular attention to geographic atrophy and the preservation of retinal structure and visual function.
- Atrophic AMD
- Geographic atrophy
- Retinal disease
The sponsor’s clinical activity is centered on eye disease research intended to address progressive degeneration of the macula and related loss of central vision.
Ophthalmology and Vision Preservation
The research portfolio is rooted in ophthalmology, with interest in therapies for conditions that affect the retina, macula, and long-term visual acuity.
- Macular pathology
- Central vision impairment
- Degenerative eye disorders
Clinical work in this area reflects a therapeutic focus on slowing disease progression in chronic retinal disorders.
Geographic Atrophy Intervention Research
ONL Therapeutics is engaged in research related to geographic atrophy, a late-stage manifestation of AMD associated with progressive loss of retinal tissue.
- Progressive retinal atrophy
- Macular degeneration
- Chronic degenerative eye disease
This therapeutic domain is directed toward patients with advanced retinal damage and unmet ophthalmic needs.
